From: The role of PDGFRA as a therapeutic target in young colorectal cancer patients
PDC | Age | Sex | Cancer type | Stage | Cell type |
---|---|---|---|---|---|
#1 | 40 | M | Adenocarcinoma | IIIb | Poorly differentiated |
#2 | 28 | F | Adenocarcinoma | IIIb | Moderately differentiated |
#3 | 83 | F | Adenocarcinoma | IIIb | Moderately differentiated |
#4 | 80 | M | Adenocarcinoma | IIIb | Moderately differentiated |